(Adds Citi analysts' comments)
** Shares of ultrasound disinfector producer Nanosonics Ltd
NAN.AX rise as much as 11.3% to A$5.030, their biggest
intraday pct gain since June 24
** Co expects to see sustainable growth across regions in
mainland Europe and the Middle East with current investments in
place
** Analysts at Citi, however, say it remains unclear if or
when adoption will ramp up significantly in the Europe/Middle
East and Asia-Pacific regions
** NAN expects R&D expenditures as a percentage of revenue
to reduce towards industry benchmarks of 12%
** Citi says NAN will not make a material profit until at
least FY25; maintains "sell" rating and A$4.05 price target
** Shares hit their highest levels since Aug. 18
** Stock up for four straight weeks so far, adding over 3.7%
in value, but down 28.4% this year as of last close, vs 4.2%
decrease in the benchmark S&P/ASX 200 index .AXJO
(Reporting by Roushni Nair and Harshita Swaminathan in
Bengaluru)
((Roushni.Nair@thomsonreuters.com;
Harshita.Swaminathan@thomsonreuters.com))